N Verses Capital, LLC Care Dx, Inc. Transaction History
N Verses Capital, LLC
- $219 Billion
- Q3 2024
A detailed history of N Verses Capital, LLC transactions in Care Dx, Inc. stock. As of the latest transaction made, N Verses Capital, LLC holds 3,300 shares of CDNA stock, worth $74,514. This represents 0.05% of its overall portfolio holdings.
Number of Shares
3,300
Previous 1,200
175.0%
Holding current value
$74,514
Previous $18.6 Million
452.92%
% of portfolio
0.05%
Previous 0.01%
Shares
2 transactions
Others Institutions Holding CDNA
# of Institutions
219Shares Held
51.1MCall Options Held
97.3KPut Options Held
43.3K-
Black Rock Inc. New York, NY5.29MShares$119 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.54MShares$102 Million0.0% of portfolio
-
Bellevue Group Ag Kuesnacht, V83.15MShares$71 Million1.65% of portfolio
-
Cathie Wood Ark Investment Management LLC | St. Petersburg, Fl2.99MShares$67.5 Million0.89% of portfolio
-
State Street Corp Boston, MA2.04MShares$46 Million0.0% of portfolio
About CareDx, Inc.
- Ticker CDNA
- Exchange NASDAQ
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 53,458,100
- Market Cap $1.21B
- Description
- CareDx, Inc. discovers, develops, and commercializes diagnostic solutions for transplant patients and caregivers worldwide. It provides AlloSure Kidney, a donor-derived cell-free DNA (dd-cfDNA) solution for kidney transplant patients; AlloMap Heart, a gene expression solution for heart transplant patients; AlloSure Heart, a dd-cfDNA solution for...